Eucrates Biomedical Acquisition Corp.
SEC CIK 1822929 · EUCR · last insider filing 2020-11-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Saxena Parag | Director · Chief Executive Officer | filed 2020 - 2020 |
| Papadopoulos Stelios | Director | filed 2020 - 2020 |
| Campbell William I | Director | filed 2020 - 2020 |
| Shapiro Nina B. | Director | filed 2020 - 2020 |
| Karydas Daphne | Director | filed 2020 - 2020 |
| Vergetis Evangelos | Director · President, COO | filed 2020 - 2020 |
| Singhal Amitabh | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Agarrwal Atanuu | Vice President | filed 2020 - 2020 |
| Cordova Gonzalo | Chief Financial Officer | filed 2020 - 2020 |
| Sathe Shrikant | Senior Vice President | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.